Speakers

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Abby Hobbs.

2016 Confirmed speakers:

Vincent Stoll, Associate Director, Structural Biology
AbbVie

Leticia Toledo-Sherman, Director of Computer-Aided Drug Design & Medicinal Chemistry
CHDI Foundation

Jennifer Riggs-Sauthier, Vice-President, Chemistry
Nektar Therapeutics

Hicham Alaoui, Director, Biochemical & Cellular Pharmacology
Genentech

Thomas Högberg, Senior Scientific Advisor
LEO Pharma

Jim Brown, Director & Senior Research Fellow, Computational Biology,
GlaxoSmithKline

Lidio Meireles, Research Scientist II
Vertex Pharmaceuticals

Arijit Chakravarty, Director, Modeling & Simulation (DMPK)
Takeda Pharmaceutical

Paul Greenspan, Senior Director of Discovery Chemistry
Takeda

Radu Dobrin, Associate Director
J&J

Michael Letavic, Scientific Director and Fellow
Janssen

Christopher Winrow, Director, Neurology & Insomnia
Merck Research Laboratories

Ozan Alkan, Principle Scientist & Research Team Leader
Merrimack Pharmaceuticals

Chris Gibson, Chief Executive Officer
Recursion Pharmaceuticals

Karin Briner, Vice President
Novartis

Asim Siddiqui, CTO
NuMedii

Mark Currie, Senior Vice President, Chief Scientific Officer & President of R&D
Ironwood Pharmaceuticals

Punit Seth, Vice President
Ionis Pharmaceuticals

Scott Davis, Manager, Screening & Assay Development
Regulus Therapeutics

Huijun Wang, Associate Principle Scientist
Merck

Derek Ostertag, Director R&D Diagnostics
Tocagen

Svetlana Belyanskaya, Manager
GlaxoSmithKline

Dean Brown, Director of External Chemistry
AstraZeneca Pharmaceuticals

Chris De Savi, Director of Medicinal Chemistry
Blueprint Medicines

C. B. Gurumurthy, Assistant Professor, Developmental Neuroscience, Director, Mouse Genome Engineering Core Facility
University of Nebraska Medical Center

Daniel McMasters, Director, Modeling & Informatics
Vertex Pharmaceuticals

Sham Nikam, VP, Head of Extra Value Generation & General Medicine Drug Discovery Unit
Takeda Pharmaceutical Company Ltd